（记者 王晓波） 欧普康视（300595.SZ）8月13日在投资者互动平台表示，我司参股40%的创投基金有投资合肥哈工艾斯 德康。哈工艾斯德康目前研发的是非侵入式脑机接口技术在孤独症（自闭症）谱系障碍中的创新应用， 已取得脑电采集类二类医疗器械注册证并上市推广。 每经AI快讯，有投资者在投资者互动平台提问：欧普康视与艾斯德康合作研发的"脑机接口视力康复设 备"目前处于哪个研发阶段？是否已启动临床试验？若已启动，处于Ⅰ期、Ⅱ期还是Ⅲ期？ ...

机器之心报道 编辑：Panda Neuralink，一家或许代表着人与机器共生未来的公司，或将迎来一个有力的挑战者。 据《金融时报》报道，OpenAI 及其联合创始人山姆・奥特曼正准备投资一家名为 Merge Labs 的创业公司，该公司的目标与伊隆・马斯克的 Neuralink 一 致，都是连接人脑与计算机。 无疑，此举将加剧这两位亿万富翁企业家之间的竞争。 《金融时报》表示未能从 OpenAI 处获得对此事件的评论，而马斯克对此的评价是： 具体来说，该媒体从三位知情人士得到了消息，称 Merge Labs 目前正在以 8.5 亿美元的估值筹集新资金，预计大部分新资金将来自 OpenAI 的风险投资团 队。两位知情人士表示，奥特曼很鼓励这项投资，并将与 Alex Blania 一起帮助启动该项目。Alex Blania 目前负责一个眼球扫描数字身份证项目 World， 该项目也得到了奥特曼的支持。他们补充说，奥特曼也将成为该公司的联合创始人，但不参与新项目的日常工作。 博客节选，https://blog.samaltman.com/the-merge 更重要的是，除非我们先毁灭自己，否则超人级 AI 终将出 ...

Core Insights - The Hang Seng Healthcare Index (HSHCI) has shown a strong increase of 1.66%, with notable gains in constituent stocks such as Weigao (9.05%) and Innovent Biologics (4.41%) [3] - The Hang Seng Medical ETF (513060) has risen by 0.89%, with a recent price of 0.68 yuan, and has accumulated a 15.41% increase over the past month, ranking in the top third among comparable funds [3] - The Hang Seng Hong Kong Stock Connect Innovative Drug Selection Index (HSSCPB) has also increased by 1.63%, with significant contributions from stocks like Innovent Biologics and Kangtai Biologicals [5] Market Dynamics - The National Healthcare Security Administration has announced the preliminary review of 121 innovative drugs for inclusion in the commercial insurance innovative drug directory, which is expected to enhance payment accessibility and commercial expectations for these products [5][6] - The medical device sector is experiencing positive sentiment due to clear technological routes and industrialization goals for brain-computer interfaces, which are expected to boost high-end medical equipment and surgical robotics [6] Investment Trends - The innovative drug sector has seen significant year-to-date gains, leading to some profit-taking and short-term volatility, while the medical device sector is attracting marginal inflows due to favorable policies and industry trends [7] - Analysts suggest focusing on companies with strong cash flow and commercial certainty in the innovative drug space, while the medical device sector is recommended for its policy-driven opportunities [8] ETF Performance - The Hang Seng Medical ETF has a current scale of 73.29 billion yuan, ranking in the top third among comparable funds, with a net value increase of 39.30% over the past two years [11][12] - The ETF has demonstrated a maximum monthly return of 28.34% since inception, with an average monthly return of 7.42% [12] - The Hang Seng Medical ETF has a tracking error of 0.060%, the highest precision among comparable funds, and its latest P/E ratio is 29.88, indicating a historical low valuation [16] Fund Characteristics - The Hong Kong Innovative Drug Selection ETF (520690) has seen a significant increase in scale, with a recent size growth of 27.29 million yuan, ranking in the top half among comparable funds [18] - The ETF has achieved a new high in shares at 404 million, with continuous net inflows over the past four days [19] - The management fee for both ETFs is 0.50%, with the Hong Kong Innovative Drug Selection ETF having the lowest custody fee at 0.10% among comparable funds [21]

A股开盘，三大指数集体高开，沪指涨0.07%。深证成指涨0.17%，创业板指涨0.33%。沪指盘初拉升， 涨0.24%至3674.5点，突破去年10月8日高点3674.4点，创下2021年12月以来新高。盘面上，零售、免税 店板块高开，合百集团2连板，国光连锁、武商集团涨停，两项贷款贴息政策出台，明确支持消费与服 务业；地产股普涨，衢州发展涨停，电子城涨超9%；锂矿股继续回调，盛新锂能跌超3%，天齐锂业跌 超2%；脑机接口概念低开，际华集团跌超5%，翔宇医疗跌超2%。贵州茅台跌约0.6%，上半年净利454 亿元，同比增9%。(格隆汇) ...

Core Viewpoint - The A-share market is experiencing a collective rise, with the Shanghai Composite Index up by 0.07% and the ChiNext Index up by 0.33%, driven by sectors such as duty-free and AI, while sectors like brain-computer interfaces, energy metals, and photovoltaics are declining [1] Group 1: Market Outlook - Shenwan Hongyuan suggests that the bull market atmosphere will not easily dissipate, and small-cap growth stocks may continue to outperform until a clear market trend is established [1] - The potential directions for a bull market include domestic technological breakthroughs and high global market share manufacturing reversing "involution" [1] - The market is expected to maintain its characteristics of sector rotation and high micro-level activity, with new opportunities arising from individual stock events [1] Group 2: Liquidity and Investment Strategy - Galaxy Securities indicates that with improved liquidity, the market is likely to operate at a high oscillation level, focusing on sectors with strong performance [2] - The margin financing balance has risen above 2 trillion yuan, but remains below historical peaks, suggesting a stable market environment [2] - The "anti-involution" theme is expected to persist, with growth sectors benefiting from the AI technology revolution and emerging industry trends [2] Group 3: Sector Focus - Dongfang Securities emphasizes that the market's upward trend remains intact, with a focus on sectors such as defense, AI computing power, semiconductors, and humanoid robots [3] - The market may experience short-term adjustments, providing opportunities for increased allocation in active sectors [3]

A股开盘，三大指数集体高开，沪指涨0.07%。深证成指涨0.17%，创业板指涨0.33%。沪指盘初拉升， 涨0.24%至3674.5点，突破去年10月8日高点3674.4点，创下2021年12月以来新高。盘面上，零售、免税 店板块高开，合百集团2连板，国光连锁、武商集团涨停，两项贷款贴息政策出台，明确支持消费与服 务业；地产股普涨，衢州发展涨停，电子城涨超9%；锂矿股继续回调，盛新锂能跌超3%，天齐锂业跌 超2%；脑机接口概念低开，际华集团跌超5%，翔宇医疗跌超2%。贵州茅台跌约0.6%，上半年净利454 亿元，同比增9%。(格隆汇) ...

中信证券发布研报称，脑机接口行业生态正在快速演进，商业化路径日益清晰。脑机接口技术发展可以 恢复身体功能、提升认知能力，实现人与机器协同工作，最后从长远来看，脑机接口技术将推动人类与 机器的共同进化，这不仅将改变我们的生活方式，还将带来新的社会和经济结构。建议关注：1)医疗级 产品快速落地的领先企业；2)消费级产品培育能力优秀的创新公司；3)具有脑机接口关键技术积累的公 司。 中信证券主要观点如下： 脑机接口生态持续演进，商业化落地迎来曙光 脑机接口是一种接连接大脑与外部设备的技术，其核心技术在于解析大脑复杂神经活动中蕴含的信息， 突破传统神经肌肉传导路径的限制，实现大脑与设备之间的双向通信与控制。(半)侵入式脑机接口在疾 病诊疗市场大有可为，非侵入式是消费市场的主流选择。根据Precedence Research研究数据，全球BCI 市场规模有望从2023年的23.5亿美元成长至2033年的108.9亿美元，对应CAGR为16.6%;根据《脑机接口 技术发展与应用研究报告(2023年)》(中国信通院)，医疗是主要产业化方向，占比56%，工业、军事、 娱乐等其他场景占比44%，商业化空间广阔。 严肃医疗领域研 ...

Core Insights - The article discusses the performance of various ETFs and sectors in the market, highlighting significant trends and investment opportunities in the technology and healthcare sectors, particularly focusing on AI and medical devices [1][6]. Market Overview - The market temperature gauge indicates a 75% bullish sentiment based on the historical P/E ratios of major indices as of August 12, 2025 [1]. - The Shanghai Composite Index, ChiNext Index, and Shenzhen Component Index show varying performance, with the Shanghai Composite Index at 0.50%, ChiNext Index at 0.53%, and Shenzhen Component Index at 1.24% [1]. Sector Performance - The top-performing sectors include Electronics (+2.24%), Communication (+1.88%), and Coal (+1.01%), while the lagging sectors are Real Estate (-0.46%), Food & Beverage (-0.83%), and Household Appliances (-1.03%) [2]. - The net inflow of capital is highest in the Electronics sector with 3.244 billion, followed by Communication with 1.966 billion, while the largest outflows are seen in Non-ferrous Metals (-4.786 billion), Defense Industry (-4.260 billion), and Machinery Equipment (-4.223 billion) [2]. ETF Performance - The top ETFs by performance over the last six months include the AI-focused ETFs, with the "创业板人工智能ETF华宝" showing a 19.06% increase [4]. - The "科创人工智能ETF华宝" and "双创龙头ETF" also show positive trends with increases of 2.49% and 2.38% respectively [4]. Investment Opportunities - The article highlights a "Davis Double Play" scenario in the optical module industry, suggesting that technology companies may see new investment opportunities as AI investment returns become clearer [6]. - The brain-computer interface sector is gaining traction, with potential breakthroughs expected by 2027, indicating a diverse range of applications and significant future growth potential [6]. Conclusion - The overall sentiment in the market is positive, with specific sectors like technology and healthcare presenting promising investment opportunities, particularly in AI and medical devices [1][6].

知情人士透露，Merge Labs正在进行新一轮融资，而新资金的主要来源将由OpenAI的风投提供。值得 注意的是，奥特曼将以联合创始人身份参与该项目，与现任World眼球扫描数字身份项目负责人亚历克 斯 布拉尼亚（Alex Blania）共同推动项目启动，但不直接负责Merge Labs的日常运营管理。 据媒体报道，OpenAI及其首席执行官山姆·奥特曼将支持一家新脑机接口公司Merge Labs，与马斯克的 Neuralink展开竞争。 ...

Core Viewpoints - The A-share market is currently experiencing a strong upward trend, with the Shanghai Composite Index reaching a new high for the year, approaching the previous high of 3674 points from October 8, 2022 [2][9] - Key factors driving the market include the implementation of tariff extension policies benefiting export companies, expectations of liquidity easing due to a potential interest rate cut by the Federal Reserve in September, and regulatory measures from the China Securities Regulatory Commission to control the pace of new listings [2][10] - The breakthrough of significant resistance levels often relies on the performance of major sectors such as brokerage firms, which can boost overall market sentiment and require sufficient trading volume to support the upward movement [3][10] Market Overview - On Tuesday, the A-share market showed active performance with all major indices opening higher and continuing to rise, with the ChiNext Index gaining nearly 1% in the first half of the day [5] - The semiconductor and AI chip sectors saw significant gains, while the shipping and port sectors also performed well [6][7] - The overall market sentiment was positive, with a total trading volume of 18.815 trillion yuan, indicating a healthy trading environment [6] Sector Analysis - The semiconductor sector is highlighted as a key investment opportunity, supported by national policies and increasing global demand for AI and high-performance computing, with expectations of over 15% growth in the global semiconductor market by 2025 [7][8] - The human brain engineering concept has gained traction following the release of national-level strategic initiatives, marking a significant development in the industry [8] Future Market Outlook - The A-share market is expected to maintain a "slow bull" pattern in the medium term, driven by favorable tariff negotiations, ongoing policy support, and an overall improvement in liquidity conditions [11] - Investors are advised to focus on sectors with high certainty in performance, reasonable valuations, and those benefiting from policy support, while being cautious of overvalued stocks [4][11]